IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 33 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,670 | -75.7% | 150,000 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | -8.3% | 150,000 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -60.0% | 150,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $30,000 | -63.0% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $81,000 | -10.0% | 150,000 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $90,000 | -21.1% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $114,000 | – | 150,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |